Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definitions
1.2 Base estimates & calculations
1.3 Data collection
1.4 Forecast parameters
1.5 Data validation
1.6 Data sources
1.6.1 Primary
1.6.2 Secondary
1.6.2.1 Paid sources
1.6.2.2 Public sources
Chapter 2 Executive Summary
2.1 Industry 360-degree synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Increasing incidence of skin disorders and trauma
3.2.1.2 Rising awareness and concern for aesthetic appearance
3.2.1.3 Advancements in scar treatment technologies
3.2.1.4 Increasing adoption of minimally invasive procedures
3.2.2 Industry pitfalls & challenges
3.2.2.1 High cost of treatment
3.2.2.2 Risk of adverse effects
3.3 Growth potential analysis
3.4 Technological landscape
3.5 Regulatory landscape
3.6 Porter’s analysis
3.6.1 Supplier power
3.6.2 Buyer power
3.6.3 Threat of new entrants
3.6.4 Threat of substitutes
3.6.5 Industry rivalry
3.7 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company market share analysis
4.3 Competitive positioning matrix
4.4 Strategy outlook matrix
Chapter 5 Market Estimates and Forecast, By Product, 2018 – 2032 ($ Mn)
5.1 Key trends
5.2 Topical products
5.2.1 Creams
5.2.2 Gels
5.2.3 Silicon sheets
5.2.4 Other topical products
5.3 Laser products
5.3.1 CO2 laser
5.3.2 Pulse-dyed laser
5.3.3 Other laser products
5.4 Injectables
5.5 Other products
Chapter 6 Market Estimates and Forecast, By Type, 2018 – 2032 ($ Mn)
6.1 Key trends
6.2 Atrophic scars
6.3 Hypertrophic and keloid scars
6.4 Contracture scars
6.5 Stretch marks
Chapter 7 Market Estimates and Forecast, By End-Use, 2018 – 2032 ($ Mn)
7.1 Key trends
7.2 Hospitals
7.3 Clinics
7.4 Retail pharmacies
7.5 Medical spa
7.6 Other end-users
Chapter 8 Market Estimates and Forecast, By Region, 2018 – 2032 ($ Mn)
8.1 Key trends
8.2 North America
8.2.1 U.S.
8.2.2 Canada
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 France
8.3.4 Spain
8.3.5 Italy
8.3.6 Rest of Europe
8.4 Asia Pacific
8.4.1 Japan
8.4.2 China
8.4.3 India
8.4.4 Australia
8.4.5 South Korea
8.4.6 Rest of Asia Pacific
8.5 Latin America
8.5.1 Brazil
8.5.2 Argentina
8.5.3 Mexico
8.5.4 Rest of Latin America
8.6 Middle East and Africa
8.6.1 South Africa
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Rest of Middle East and Africa
Chapter 9 Company Profiles
9.1 CCA Industries, Inc.
9.2 Clayton, Dubilier & Rice, LLC
9.3 Lumenis Be Ltd.
9.4 McKesson Corporation
9.5 Merz Pharma GmbH & Co. KGaA
9.6 Newmedical Technology Inc.
9.7 Perrigo Company plc
9.8 SMITH & NEPHEW plc
9.9 Sonoma Pharmaceuticals, Inc.
9.10 Suneva Medical
